Pancreatic enzyme trial for stomach discomfort
Part of Digestive system clinical trials.
This trial tests whether pancreatic enzyme supplements can help people with functional dyspepsia, a condition causing ongoing stomach pain or fullness without a clear cause. It is for people who do not have other digestive diseases or H. pylori infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with functional dyspepsia (ongoing stomach pain or fullness not explained by other diseases)
- You tested negative for H. pylori (a bacteria that can cause ulcers)
- You do not have other digestive diseases like celiac disease, Crohn's, or colon inflammation
- You are not pregnant or breastfeeding
- You do not have uncontrolled diabetes, thyroid problems, or cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking digestive enzyme supplements alongside standard treatment helps reduce indigestion and stomach discomfort in people with functional dyspepsia (a condition where the stomach doesn't empty food properly, even though it looks normal). The goal is to see if enzymes can improve symptoms like bloating, fullness, and nausea.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This trial is for adults aged 18 to 80 who have a Helicobacter pylori (H. pylori) infection in their stomach and have never been treated for it. The study will look at how treating the infection affects symptoms like indigestion or stomach pain.
This study looks at people with fatty liver disease linked to metabolism. It checks if they also have fat in the pancreas.
This trial tests a new blood test to measure how well your pancreas works. It may help people with chronic pancreatitis understand their condition and quality of life.
This study tests whether adding pancreatic digestive enzymes to tube feeding can improve digestion and outcomes in critically ill adults who have higher risk of not producing enough digestive enzymes. If you qualify, you may receive the enzyme supplement or a comparison treatment while you’re in the ICU.
Hear when a new Exocrine Pancreatic Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.